EEburyraised$700M·Growth|SStarcloudraised$200M·Growth|FFunraised$72M·Series A|SStandard Intelligenceraised$75M·Series A|NNetomiraised$110M·Series C|PParallel Web Systemsraised$100M·Series B|RRogoraised$160M·Series D|HHightouchraised$150M·Series D|TTrue Anomalyraised$650M·Series D|SSaronicraised$1.75B·Series D|AAvocaraised$125M·Series B|SSiFiveraised$400M·Series G|SSidewinder Therapeuticsraised$137M·Series B|HHermeusraised$350M·Series C|WWHOOPraised$575M·Series G|
NewLimitNL
NL

NewLimit

Reversing biological aging with epigenetics

Visit
AISeries AEst. 202110-50 employeesSan Francisco

NewLimit is developing therapies to extend human healthspan by reprogramming the epigenome — the software layer on top of DNA that controls gene expression. Backed by Brian Armstrong (Coinbase CEO), they aim to let humans live longer, healthier lives.

Total Raised$40M
Founders FundForesite Capital

Founders

B
Brian Armstrong
B
Blake Byers

More in AI

Signal IDXSI

Signal IDX

Real-time startup intelligence and market signals

MidjourneyMJ

Midjourney

The world's leading AI image generation model

Character.AICA

Character.AI

Chat with AI characters that feel human

← All startupsMore from USAMore AI